| Literature DB >> 12971827 |
Janet M Wojcicki1, Rob Newton, Margaret I Urban, Lara Stein, Martin Hale, Moosa Patel, Paul Ruff, Ranjan Sur, Dimitra Bourboulia, Freddy Sitas.
Abstract
BACKGROUND: Infection with human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV), is the necessary causal agent in the development of Kaposi's sarcoma (KS). Infection with HIV-1, male gender and older age all increase risk for KS. However, the geographic distribution of HHV-8 and KS both prior to the HIV/AIDS epidemic and with HIV/AIDS suggest the presence of an additional co-factor in the development of KS.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12971827 PMCID: PMC222909 DOI: 10.1186/1471-2334-3-21
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Sociodemographic Characteristics of Participants in relation to HHV-8 seropositivity and anti-HHV-8 titer level.
| Total | No. HHV-8 neg (%) | No. HHV-8 pos (%) | No. low titer (%) | No. med. titer (%) | No. high titer (%) | |
| 2191 | 1337 (61.0) | 854 (39.0) | 530 (62.1) | 227 (26.6) | 97 (11.4) | |
| Male | 857 (39.1) | 522 (60.9) | 335 (39.1) | 207 (61.8) | 85 (25.4) | 43 (12.8) |
| Female | 1334 (60.9) | 815 (61.1) | 519 (38.9) | 323 (62.2) | 142 (27.4) | 54 (10.4) |
| <35 | 205 (9.4) | 157 (76.6) | 48 (23.4) | 38(79.2) | 9(18.8) | 1 (2.1) |
| 35–44 | 333 (15.2) | 220 (66.1) | 113 (33.9) | 77 (68.1) | 31(27.4) | 5 (4.4) |
| 45–54 | 533 (24.4) | 343 (64.4) | 190 (35.7) | 121 (63.7) | 51 (26.8) | 18(9.5) |
| 55–64 | 539 (24.6) | 319 (59.2) | 220 (40.8) | 133 (60.5) | 60(27.3) | 27(12.3) |
| ≥ 65 | 578 (26.4) | 297 (51.4) | 281(48.6) | 159 (56.6) | 76(27.1) | 46(16.4) |
| Single | 527 (24.1) | 352 (66.8) | 175 (33.2) | 124 (70.9) | 42 (24.0) | 9 (5.1) |
| Married | 1161 (53.1) | 703 (60.6) | 458 (39.5) | 292 (63.8) | 115 (25.1) | 51 (11.1) |
| Widowed | 344 (15.7) | 182 (52.9) | 162 (47.1) | 87 (53.7) | 52 (32.1) | 23 (14.2) |
| Divorced | 153 (7.0) | 95 (62.1) | 58 (37.9) | 27 (46.6) | 18 (31.0) | 13 (22.4) |
| Separated | ||||||
| 0–2 | 455 (22.6) | 288(63.3) | 167 (36.7) | 103 (61.7) | 47 (28.1) | 17 (10.2) |
| 3–4 | 1051 (52.2) | 628(59.8) | 423 (40.3) | 267 (63.1) | 111 (26.2) | 45 (10.6) |
| ≥ 5 | 508 (25.2) | 306(60.2) | 202 (39.8) | 123 (60.9) | 51 (25.3) | 28 (13.9) |
| None | 581 (26.7) | 310 (53.4) | 271 (46.6) | 153 (56.5) | 82 (30.3) | 36 (13.3) |
| 1–5 years | 878 (40.3) | 539 (61.4) | 339 (38.6) | 219 (64.6) | 83 (24.5) | 37 (10.9) |
| ≥ 6 years | 719 (33.0) | 479 (66.6) | 240 (33.4) | 156 (65.0) | 60 (25.0) | 24 (10.0) |
| White-collar | 270 (13.5) | 181 (67.0) | 89 (33.0) | 52 (58.4) | 25 (28.1) | 12 (13.5) |
| Non-active | 237 (11.8) | 138 (58.2) | 99 (41.8) | 68 (68.7) | 21 (21.2) | 10 (10.1) |
| Farming | 97 (4.8) | 56 (57.7) | 41 (42.3) | 27 (65.9) | 7 (17.1) | 7 (17.1) |
| Industry | 559 (27.9) | 378 (67.6) | 181 (32.4) | 109 (60.2) | 47 (26.0) | 25 (13.8) |
| Domestic | 756 (37.7) | 424 (56.1) | 332 (43.9) | 202 (60.8) | 97 (29.2) | 33 (9.9) |
| Unspecified | 88 (4.4) | 56 (63.6) | 32 (36.4) | 17 (53.1) | 10 (31.3) | 5 (15.6) |
| Rural | 1245 (59.0) | 729 (58.6) | 516 (41.5) | 324 (62.8) | 133 (25.8) | 59 (11.4) |
| Urban | 866 (41.0) | 553 (63.9) | 313 (36.1) | 188 (60.1) | 89 (28.4) | 36 (11.5) |
| Urban | 1698 (79.6) | 1038 (80.0) | 259 (20.0) | 413 (62.6) | 170 (25.8) | 77 (11.7) |
| Rural | 435 (20.4) | 660 (79.0) | 176 (21.1) | 103 (58.5) | 54 (30.7) | 19 (10.8) |
Socio-demographic factors in relation to the risk of high anti-HHV-8 titers (≥ 1:51, 200) *
| Characteristic | high titer/total pos (%)¥ | aOR * 95%CI |
| Male§ | 128/335 (38.2) | 1.0 |
| Female | 196/518 (37.8) | 1.08 (0.80–1.45) |
| Test of Homogeneity¶ | χ2 = 0.25, p = 0.62 | |
| <35§ | 10/48 (20.8) | 1.0 |
| 35–44 | 36/113 (31.9) | 1.76 (0.79–3.93) |
| 45–54 | 69/190 (36.3) | 2.16 (1.01–2.41) |
| 55–64 | 87/220 (39.6) | 2.48 (1.18–5.25) |
| ≥ 65 | 122/281 (43.4) | 2.96 (1.42–6.19) |
| Test for trend¶ | χ2 = 11.16, p = 0.001 | |
| None§ | 118/270 (43.7) | 1.0 |
| 1–5 | 120/339 (35.4) | 0.75 (0.54–1.05) |
| ≥ 6 years | 84/240 (35.0) | 0.83 (0.57–1.21) |
| Test for trend¶ | χ2 = 1.08, p = 0.30 | |
| Rural § | 192/516 (37.2) | 1.0 |
| Urban | 125/312 (40.1) | 1.29 (0.95–1.74) |
| Test of Homogeneity¶ | χ2 = 2.73, p = 0.10 | |
| Other§ | 212/558 (38.0) | 1.0 |
| Gauteng | 112/290 (38.6) | 1.16 (0.85–1.56) |
| Test of Homogeneity¶ | χ2 = 0.84, p = 0.36 | |
| Urban§ | 247/659 (37.5) | 1.0 |
| Rural | 73/176 (41.5) | 1.26 (0.89–1.78) |
| Test of Homogeneity¶ | χ2 = 1.84, p = 0.18 | |
| Gauteng§ | 243/648 (37.5) | 1.0 |
| Other | 81/205 (39.5) | 1.15 (0.83–1.60) |
| Test of Homogeneity¶ | χ2 = 0.82, p = 0.37 |
* Adjusted for age category < 35, 35–44, 45–54, 55–64, or ≥ 65 and sex. ¥ Data were not available for all patients for all variables. § These patients served as the reference group. ¶ All values were calculated with the χ2 test with 1 df unless noted otherwise.
Some factors characterizing wealth in relation to high anti-HHV-8 antibody titers*
| Characteristic | high titer/total pos (%)¥ | aOR * 95%CI |
| Brick§ | 268/727 (36.9) | 1.0 |
| Other | 56/127 (44.1) | 1.49 (1.01–2.21) |
| Test of Homogeneity¶ | χ2 = 4.04, p = 0.04 | |
| Inside home§ | 308/808 (38.1) | 1.0 |
| Outside home | 16/45 (35.6) | 0.92 (0.49–1.73) |
| Test of Homogeneity¶ | χ2 = 0.06, p = 0.80 | |
| Electricity § | 229/597 (38.4) | 1.0 |
| Other | 95/256 (37.1) | 0.99 (0.73–1.34) |
| Test of Homogeneity¶ | χ2 = 0.01, p = 0.93 | |
| Electricity§ | 228/595 (38.3) | 1.0 |
| Other | 96/258 (37.2) | 1.00 (0.73–1.35) |
| Test of Homogeneity¶ | χ2 = 0.00, p = 0.98 | |
| Inside§ | 282/749 (37.7) | 1.0 |
| Outside | 41/108 (39.8) | 1.10 (0.72–1.69) |
| Test of Homogeneity¶ | χ2 = 0.20, p = 0.65 | |
| Other§ | 306/771 (39.7) | 1.0 |
| Electricity | 17/81 (21.0) | 0.44 (0.25–0.78) |
| Test of Homogeneity¶ | χ2 = 8.08, p = 0.005 | |
| Other§ | 307/773 (39.7) | 1.0 |
| Electricity | 16/79 (20.3) | 0.43 (0.25–0.73) |
| Test of Homogeneity¶ | χ2 = 8.5, p = 0.004 | |
| No§ | 142/432 (32.9) | 1.0 |
| Yes/ | 160/365 (43.8) | 1.56 (1.16–2.08) |
| (More than 5 Years) | ||
| Test of Homogeneity¶ | χ2 = 8.82, p = 0.003 | |
| No§ | 261/673 (38.7) | 1.0 |
| Yes | 54/167 (32.3) | 0.85 (0.58–1.26) |
| Test of Homogeneity¶ | χ2 = 0.72, p = 0.39 | |
| No§ | 153/449 (34.1) | 1.0 |
| Yes | 163/392 (41.6) | 1.01 (0.67–1.52) |
| Test of Homogeneity¶ | χ2 = 0.00, p = 0.97 | |
| White-collar§ | 37/89 (41.6) | 1.0 |
| Non-active | 31/99 (31.3) | 0.71 (0.38–1.33) |
| Farming | 14/41 (34.2) | 0.63 (0.29–1.38) |
| Industry | 72/181 (39.8) | 0.85 (0.50–1.44) |
| Domestic | 130/331 (39.3) | 0.85 (0.52–1.41) |
| Unspecified | 15/32 (46.9) | 1.53 (0.65–3.59) |
| Test of Homogeneity¶ | χ2 (5df) = 4.49, p = 0.48 |
* Adjusted for age category < 35, 35–44, 45–54, 55–64, or ≥ 65 and sex. ¥ Data were not available for all patients for all variables. § These patients served as the reference group. ¶ All values were calculated with the χ2 test with 1 df unless noted otherwise.
Factors related to smoking and alcohol use in relation to high anti-HHV-8 antibody titers*
| Characteristic | High titer/total pos (%)¥ | aOR * 95%CI |
| No§ | 179/486 (36.8) | 1.0 |
| Past | 96/233 (41.2) | 1.12 (0.77–1.62) |
| Yes | 46/128 (35.9) | 1.00 (0.64–1.57) |
| Test of Homogeneity¶ | χ2 (2df) = 0.43, p = 0.80 | |
| No§ | 255/691 (36.9) | 1.0 |
| Past | 22/57 (38.6) | 0.97 (0.54–1.71) |
| Current | 47/101 (46.5) | 1.48 (0.95–2.30) |
| Test of Homogeneity¶ | χ2 (2df) = 2.56, p = 0.11 | |
| Never§ | 277/761 (36.4) | 1.0 |
| Less than 1× week | 18/50 (36.0) | 0.92 (0.51–1.69) |
| More than 1× week | 13/17 (76.5) | 5.10 (1.64–15.87) |
| Most days | 13/20 (65.0) | 3.07 (1.19–7.90) |
| Test for Trend¶ | χ2 = 9.49, p = 0.002 | |
| Never§ | 250/692 (36.1) | 1.0 |
| Less than 1× week | 47/116 (40.5) | 1.12 (0.74–1.70) |
| More than 1× week | 15/25 (60.0) | 2.46 (1.08–5.64) |
| Most days | 7/13 (53.9) | 1.93 (0.64–5.86) |
| Test for Trend¶ | χ2 = 4.29, p = 0.04 | |
| Never§ | 249/636 (39.2) | 1.0 |
| Less than 1× week | 43/151 (28.5) | 0.52 (0.34–0.78) |
| More than 1× week | 18/38 (47.4) | 1.18 (0.60–2.31) |
| Most days | 7/18 (38.9) | 0.91 (0.34–2.41) |
| Test for Trend¶ | χ2 = 1.46, p = 0.23 | |
| Never§ | 284/776 (36.6) | 1.0 |
| Less than 1× week | 15/27 (55.6) | 2.26 (1.03–5.00) |
| More than 1× week | 4/8 (50.0) | 1.60 (0.39–6.53) |
| Most days | 13/25 (52.0) | 2.05 (0.91–4.60) |
| Test for Trend¶ | χ2 = 5.11, p = 0.02 | |
| Never§ | 187/508 (36.8) | 1.0 |
| Less than 1× week | 21/48 (43.8) | 1.32 (0.72–2.43) |
| More than 1× week | 38/81 (46.9) | 1.35 (0.83–2.21) |
| Most days | 74/211 (35.1) | 0.85 (0.58–1.250 |
| Test for Trend¶ | χ2 = 0.24=, p = 0.63 | |
| Never§ | 257/680 (37.8) | 1.0 |
| Less than 1× week | 29/82 (35.4) | 0.85 (0.52–1.39) |
| More than 1× week | 12/39 (30.8) | 0.68 (0.33–1.41) |
| Most days | 22/45 (48.9) | 1.59 (0.85–2.99) |
| Test for Trend¶ | χ2 = 0.37, p = 0.54 | |
| Never§ | 278/733 (37.9) | 1.0 |
| Less than 1× week | 23/68 (33.8) | 0.83 (0.49–1.41) |
| More than 1× week | 3/6 (50.0) | 1.58 (0.31–8.01) |
| Most days | 13/27 (48.2) | 1.63 (0.75–3.56) |
| Test for Trend¶ | χ2 = 0.90, p = 0.34 | |
| No§ | 162/432 (37.5) | 1.0 |
| Yes | 159/416 (38.2) | 0.94 (0.69–1.29) |
| Test of Homogeneity¶ | χ2= 0.13, p = 0.72 | |
| No§ | 245/682 (35.9) | 1.0 |
| Yes | 75/166 (45.2) | 1.37 (0.95–1.97) |
| Test of Homogeneity¶ | χ2 = 2.85, p = 0.09 |
* Adjusted for age category < 35, 35–44, 45–54, 55–64, or ≥ 65 and sex. ¥ Data were not available for all patients for all variables. § These patients served as the reference group. ¶ All values were calculated with the χ2 test with 1 df unless noted otherwise.
Factors related to sexual exposures and reproduction in relation to high anti-HHV-8 antibody titers
| high titer/total pos (%)¥ | aOR * 95%CI | |
| 0–1§ | 247/633 (39.0) | 1.0 |
| ≥ 2 | 20/45 (44.4) | 1.26 (0.68–2.35) |
| Test for Trend¶ | χ2 = 0.55, p = 0.46 | |
| Single§ | 51/175 (29.1) | 1.0 |
| Married | 166/458 (36.2) | 1.11 (0.73–1.69) |
| Widowed | 75/162 (46.3) | 1.54 (0.92–2.59) |
| Separated/Divorced | 31/57 (54.4) | 2.44 (1.30–4.58) |
| Test of Homogeneity¶ (3 df) | χ2 = 10.6, p = 0.01 | |
| 0–2§ | 64/166 (38.6) | 1.0 |
| 3–4 | 156/423 (36.9) | 0.94 (0.65–1.38) |
| ≥ 5 | 79/202 (39.1) | 1.11 (0.71–1.74) |
| Test for Trend¶ | χ2 = 0.37, p = 0.54 | |
| Yes§ | 189/501 (37.7) | 1.0 |
| No | 8/17 (47.1) | 1.65 (0.61–4.49) |
| Test of Homogeneity¶ | χ2 = 0.95, p = 0.33 | |
| 1§ | 11/39 (28.2) | 1.0 |
| 2–3 | 57/149 (38.3) | 1.69 (0.77–3.69) |
| 4–5 | 54/142 (38.0) | 1.50 (0.68–3.29) |
| ≥ 6 | 68/173 (39.3) | 1.45 (0.67–3.15) |
| Test for Trend¶ | χ2 = 0.03, p = 0.87 | |
| 0§ | 6/12 (50.0) | 1.0 |
| 1 | 37/107 (34.6) | 0.56 (0.17–1.89) |
| ≥ 2 | 39/100 (39.0) | 0.61 (0.18–2.06) |
| Test for Trend¶ | χ2 = 0.10, p = 0.73 | |
| 0–2§ | 53/140 (37.9) | 1.0 |
| 3–4 | 57/174 (32.8) | 0.73 (0.45–1.18) |
| ≥ 5 | 74/176 (42.1) | 0.99 (0.62–1.59) |
| Test for Trend¶ | χ2 = 0.00, p = 0.95 | |
| 0–1§ | 10/26 (38.5) | 1.0 |
| 2–3 | 29/82 (35.4) | 0.80 (0.31–2.06) |
| 4–5 | 31/80 (38.8) | 0.76 (0.29–2.01) |
| ≥ 6 | 49/126 (38.9) | 0.69 (0.26–1.79) |
| Test for Trend¶ | χ2 = 0.50, p = 0.48 | |
| 1§ | 237/608 (39.0) | 1.0 |
| ≥ 2 | 67/197 (34.0) | 0.82 (0.58–1.16) |
| Test for Trend¶ | χ2 = 1.30, p = 0.25 | |
| 10–13§ | 17/39 (43.6) | 1.0 |
| 14 | 34/81 (42.0) | 0.93 (0.42–2.04) |
| 15 | 53/166 (31.9) | 0.55 (0.27–1.14) |
| ≥ 16 | 91/227 (40.1) | 0.77 (0.38–1.56) |
| Test for Trend¶ | χ2 = 0.46, p = 0.50 | |
| ≤ 45§ | 32/94 (34.0) | 1.0 |
| 46–49 | 40/100 (40.0) | 1.11(0.60–2.08) |
| ≥ 50 | 85/198 (42.9) | 1.24 (0.69–2.23) |
| Test for Trend¶ | χ2 = 0.74, p = 0.39 | |
| No§ | 168/424 (39.6) | 1.0 |
| Yes | 25/86 (29.1) | 0.69 (0.40–1.17) |
| Test of Homogeneity¶ | χ2 = 1.88, p = 0.17 | |
| No§ | 165/425 (38.8) | 1.0 |
| Yes | 28/87 (32.2) | 0.93 (0.55–1.59) |
| Test of Homogeneity¶ | χ2 = 0.07, p = 0.80 |
* Adjusted for age category < 35, 35–44, 45–54, 55–64, or ≥ 65 sex. ¥ Data were not available for all patients for all variables. § These patients served as the reference group. ¶ All values were calculated with the χ2 test with 1 df unless noted otherwise.
Risk factors for high anti-HHV-8 antibody titers
| OR (high titers)‡ | (95%CI) | |
| <35§ | 1.0 | |
| 35–44 | 1.64 (0.71–3.77) | 0.25 |
| 45–54 | 1.79(0.80–3.98) | 0.16 |
| 55–64 | 2.03 (091–4.57) | 0.09 |
| ≥ 65 | 2.38 (1.04–5.44) | 0.04 |
| Test for trend† | χ2 = 4.45, p = 0.04 | |
| Rural§ | 1.0 | |
| Urban | 1.33 (0.97–1.84) | 0.08 |
| Test of Homogeneity† | χ2 = 3.10, p = 0.08 | |
| Brick§ | 1.0 | |
| Other | 1.43 (0.94–2.17) | 0.09 |
| Test of Homogeneity† | χ2 = 2.86, p = 0.09 | |
| Other§ | 1.0 | |
| Electricity | 0.50 (0.27–0.91) | 0.02 |
| Test of Homogeneity† | χ2 = 5.19, p = 0.02 | |
| No§ | 1.0 | |
| Yes/(More than 5 Years) | 1.27 (0.92–1.75) | 0.14 |
| Test of Homogeneity† | χ2 = 2.16, p = 0.14 | |
| Single§ | 1.0 | |
| Married | 1.20 (0.77–1.85) | 0.42 |
| Widowed | 1.52 (0.89–2.59) | 0.13 |
| Separated/Divorced | 2.73 (1.41–5.28) | 0.003 |
| Test of Homogeneity† (3df) | χ2 = 10.31, p = 0.02 | |
| Never§ | 1.0 | |
| Less than 1× week | 0.74 (0.38–1.42) | 0.36 |
| More than 1× week | 4.16 (1.26–13.80) | 0.02 |
| Most Days | 2.18 (0.79–6.04) | 0.13 |
| Test for Trend† | χ2 = 3.72, p = 0.05 | |
| Never§ | 1.0 | |
| Less than 1× week | 2.16 (0.93–5.03) | 0.07 |
| More than 1× week | 1.00 (.20–5.05) | 0.99 |
| Most Days | 1.68 (0.72–3.92) | 0.23 |
| Test for Trend† | χ2 = 2.25, p = 0.13 |
† All values were calculated with the χ2 test with 1df unless noted otherwise. ‡ In the multivariate model, all bivariately statistically significant variables at p = 0.1 are included and odds ratios are also adjusted for sex. Each variable was adjusted for all other variables in the table. The Hosmer-Lemeshow goodness-of-fit statistic = 5.66 with 8 df (p = 0.69). § These patients served as the reference group